Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk
Authors:
- Adrian CassidyACAdrian Cassidy
- Jian GuJGJian Gu
- Hushan YangHYHushan Yang
- Michelle A.T. HildebrandtMHMichelle A.T. Hildebrandt
- Jie LinJLJie Lin
- Yuanqing YeYYYuanqing Ye
- Robert M. ChamberlainRCRobert M. Chamberlain
- Xifeng WuXWXifeng Wu
Open Access
- 29 October 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 30 (12) , 2047-2052
Abstract
Genetic variations in phosphoinositide-3 kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway may affect critical cellular functions and increase an individual's cancer risk. We systematically evaluate 231 single-nucleotide polymorphisms (SNPs) in 19 genes in the PI3K-AKT-mTOR signaling pathway as predictors of bladder cancer risk. In individual SNP analysis, four SNPs in regulatory associated protein of mTOR ( RAPTOR ) remained significant after correcting for multiple testing: rs11653499 [odds ratio (OR): 1.79, 95% confidence interval (CI): 1.24–2.60, P = 0.002], rs7211818 (OR: 2.13, 95% CI: 1.35–3.36, P = 0.001), rs7212142 (OR: 1.57, 95% CI: 1.19–2.07, P = 0.002) and rs9674559 (OR: 2.05, 95% CI: 1.31–3.21, P = 0.002), among which rs7211818 and rs9674559 are within the same haplotype block. In haplotype analysis, compared with the most common haplotypes, haplotype containing the rs7212142 wild-type allele showed a protective effect of bladder cancer (OR: 0.83, 95% CI: 0.70–0.97). In contrast, the haplotype containing the rs7211818 variant allele showed a 1.32-fold elevated bladder cancer risk (95% CI: 1.09–1.60). In combined analysis of three independent significant RAPTOR SNPs (rs11653499, rs7211818 and rs7212142), a significant trend was observed for increased risk with an increase in the number of unfavorable genotypes ( P for trend <0.001). Compared with the subjects without any of the unfavorable genotypes, those carrying all three unfavorable genotypes showed a 2.22-fold (95% CI: 1.33–3.71) increased bladder cancer risk. This is the first study to evaluate the role of germ line genetic variations in PI3K-AKT-mTOR pathway as cancer susceptibility factors that will help us identify high-risk individuals for bladder cancer.Keywords
This publication has 38 references indexed in Scilit:
- A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer riskNature Genetics, 2007
- Genome-wide association study identifies novel breast cancer susceptibility lociNature, 2007
- A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancerNature Genetics, 2007
- Multiple regions within 8q24 independently affect risk for prostate cancerNature Genetics, 2007
- Segregation analysis of urothelial cell carcinomaEuropean Journal of Cancer, 2006
- Mechanisms of Disease: the epidemiology of bladder cancerNature Reviews Endocrinology, 2006
- Statistical significance for genomewide studiesProceedings of the National Academy of Sciences, 2003
- A case-control study of cyclin D1 CCND1 870A->G polymorphism and bladder cancerCarcinogenesis, 2003
- mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth MachineryCell, 2002
- Familial aggregation of urothelial cell carcinomaInternational Journal of Cancer, 2001